AMN Healthcare Posts Q4 Loss as Revenue Beats and March-Quarter Guidance Issued

Overview

• AMN reported a GAAP net loss of $7.7 million for the fourth quarter, equal to 20 cents per share.
• Adjusted earnings excluding non-recurring costs were 22 cents per share, aligning with the Zacks consensus.
• Fourth-quarter revenue reached $748.2 million, topping the $723.9 million expected by analysts surveyed by Zacks.
• The company projected revenue of $1.23 billion to $1.24 billion for the quarter ending in March.
• For the full year, the loss narrowed to $95.7 million on $2.73 billion in revenue, and shares were last quoted at $17.28, up about 10% year to date but down roughly 28% over 12 months.